GEODE CAPITAL MANAGEMENT, LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 221 filers reported holding IMMUNOGEN INC in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$77,771,950
-13.3%
4,899,975
+3.1%
0.01%
-18.2%
Q2 2023$89,680,649
+478.2%
4,752,550
+17.7%
0.01%
+450.0%
Q1 2023$15,511,287
+81362.6%
4,039,396
+5.2%
0.00%
-33.3%
Q4 2022$19,041
-99.9%
3,839,090
+3.6%
0.00%0.0%
Q3 2022$17,720,000
+6.8%
3,707,278
+0.6%
0.00%
+50.0%
Q2 2022$16,586,000
-0.1%
3,685,781
+5.6%
0.00%0.0%
Q1 2022$16,609,000
-36.9%
3,489,369
-1.6%
0.00%
-33.3%
Q4 2021$26,317,000
+35.9%
3,546,767
+3.9%
0.00%0.0%
Q3 2021$19,359,000
-19.1%
3,414,345
-6.0%
0.00%0.0%
Q2 2021$23,938,000
-16.0%
3,632,576
+3.3%
0.00%
-25.0%
Q1 2021$28,486,000
+45.0%
3,516,791
+15.4%
0.00%
+33.3%
Q4 2020$19,650,000
+97.0%
3,046,603
+9.9%
0.00%
+50.0%
Q3 2020$9,976,000
-22.4%
2,771,239
-0.9%
0.00%
-33.3%
Q2 2020$12,857,000
+37.9%
2,795,189
+2.2%
0.00%
+50.0%
Q1 2020$9,324,000
-62.3%
2,734,755
-43.5%
0.00%
-33.3%
Q4 2019$24,708,000
+340.0%
4,840,030
+108.6%
0.00%
+200.0%
Q3 2019$5,616,000
+19.2%
2,320,698
+6.9%
0.00%0.0%
Q2 2019$4,710,000
-6.8%
2,170,841
+16.4%
0.00%0.0%
Q1 2019$5,053,000
-69.4%
1,864,609
-45.7%
0.00%
-66.7%
Q4 2018$16,490,000
+7.4%
3,435,540
+112.0%
0.00%
-25.0%
Q3 2018$15,348,000
+3.9%
1,620,786
+6.8%
0.00%
-20.0%
Q2 2018$14,771,000
+31.7%
1,518,162
+42.4%
0.01%
+25.0%
Q1 2018$11,218,000
+83.2%
1,066,394
+11.6%
0.00%
+100.0%
Q4 2017$6,122,000
-9.5%
955,193
+8.0%
0.00%0.0%
Q3 2017$6,765,000
+33.4%
884,550
+24.0%
0.00%0.0%
Q2 2017$5,070,000
+93.1%
713,190
+5.1%
0.00%
+100.0%
Q1 2017$2,625,000
+96.5%
678,343
+3.5%
0.00%0.0%
Q4 2016$1,336,000
-22.0%
655,352
+2.5%
0.00%0.0%
Q3 2016$1,713,000
-10.5%
639,592
+3.0%
0.00%0.0%
Q2 2016$1,913,000
-63.8%
621,144
+0.1%
0.00%
-66.7%
Q1 2016$5,285,000
-33.8%
620,395
+5.4%
0.00%
-40.0%
Q4 2015$7,988,000
+40.5%
588,770
-0.6%
0.01%
+66.7%
Q3 2015$5,687,000
-30.8%
592,500
+3.7%
0.00%
-40.0%
Q2 2015$8,217,000
+67.0%
571,468
+4.0%
0.01%
+66.7%
Q1 2015$4,919,000
+51.2%
549,687
+3.0%
0.00%
+50.0%
Q4 2014$3,254,000
-35.9%
533,652
+11.3%
0.00%
-33.3%
Q3 2014$5,076,000
-11.1%
479,387
-0.6%
0.00%
-25.0%
Q2 2014$5,712,000
-20.4%
482,071
+0.3%
0.00%
-20.0%
Q1 2014$7,172,000
+15.6%
480,420
+13.5%
0.01%
+25.0%
Q4 2013$6,206,000
-10.7%
423,098
+3.7%
0.00%
-33.3%
Q3 2013$6,947,000
+13.6%
408,165
+10.7%
0.01%
+20.0%
Q2 2013$6,115,000368,5870.01%
Other shareholders
IMMUNOGEN INC shareholders Q3 2021
NameSharesValueWeighting ↓
Redmile Group, LLC 17,503,417$277,779,22813.22%
Fairmount Funds Management LLC 5,929,592$94,102,62511.32%
CM Management, LLC 500,000$7,935,0008.42%
SILVERARC CAPITAL MANAGEMENT, LLC 1,307,435$20,748,9936.29%
Altium Capital Management LP 725,000$11,505,7506.00%
RA Capital Management 13,322,288$211,424,7114.16%
TANG CAPITAL MANAGEMENT LLC 1,500,000$23,805,0003.36%
BRIDGER MANAGEMENT, LLC 467,220$7,414,7812.73%
Birchview Capital, LP 190,000$3,015,3002.57%
Boxer Capital, LLC 2,961,000$46,991,0702.50%
View complete list of IMMUNOGEN INC shareholders